Individuals with depression are more than two times as likely to be diagnosed with dementia Image: iStock/Obencem Individuals with depression are more than two times as likely to be diagnosed with dementia Penn Medicine research finds the risk of dementia is higher for men than women, and in individuals with multiple inpatient hospitalizations for depression.
Drilling into a model of a skull: a ‘cool’ taste of doctoring for Philly high schoolers Penn In the News Philadelphia Inquirer Drilling into a model of a skull: a ‘cool’ taste of doctoring for Philly high schoolers The “Pipeline Plus” summer program at Penn Medicine, run by the Netter Center for Community Partnerships, is designed to teach Philadelphia high school students about careers in the health sciences. A new study finds a strong link between depression and dementia Penn In the News CNN A new study finds a strong link between depression and dementia A study led by Holly C. Elser of the Perelman School of Medicine finds that adults diagnosed with depression are more than twice as likely to get dementia later in life. Young and middle-aged adults with depression face greater dementia risk later in life Penn In the News USA Today Young and middle-aged adults with depression face greater dementia risk later in life A study led by Holly C. Elser of the Perelman School of Medicine suggests a connection between dementia risk and depression diagnoses in early and mid-life. Is Parkinson’s disease an industrial disorder of our making? Penn In the News Psychology Today Is Parkinson’s disease an industrial disorder of our making? In an op-ed, Anjan Chatterjee of the Perelman School of Medicine examines Parkinson’s disease and its connection to industrialization. AI-guided brain stimulation aids memory in traumatic brain injury Image: iStock/Ozgu Arslan AI-guided brain stimulation aids memory in traumatic brain injury A collaborative study shows that targeted electrical stimulation in the brains of epilepsy patients with traumatic brain injury improved memory recall by 19%. Prescribed stimulants for ADHD and the risk of addiction Penn In the News Psychology Today Prescribed stimulants for ADHD and the risk of addiction Russell Ramsay of the Perelman School of Medicine writes about stimulants as a treatment for ADHD. Study links social isolation with shrinking brain Penn In the News Health Day Study links social isolation with shrinking brain Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one. Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
A new study finds a strong link between depression and dementia Penn In the News CNN A new study finds a strong link between depression and dementia A study led by Holly C. Elser of the Perelman School of Medicine finds that adults diagnosed with depression are more than twice as likely to get dementia later in life. Young and middle-aged adults with depression face greater dementia risk later in life Penn In the News USA Today Young and middle-aged adults with depression face greater dementia risk later in life A study led by Holly C. Elser of the Perelman School of Medicine suggests a connection between dementia risk and depression diagnoses in early and mid-life. Is Parkinson’s disease an industrial disorder of our making? Penn In the News Psychology Today Is Parkinson’s disease an industrial disorder of our making? In an op-ed, Anjan Chatterjee of the Perelman School of Medicine examines Parkinson’s disease and its connection to industrialization. AI-guided brain stimulation aids memory in traumatic brain injury Image: iStock/Ozgu Arslan AI-guided brain stimulation aids memory in traumatic brain injury A collaborative study shows that targeted electrical stimulation in the brains of epilepsy patients with traumatic brain injury improved memory recall by 19%. Prescribed stimulants for ADHD and the risk of addiction Penn In the News Psychology Today Prescribed stimulants for ADHD and the risk of addiction Russell Ramsay of the Perelman School of Medicine writes about stimulants as a treatment for ADHD. Study links social isolation with shrinking brain Penn In the News Health Day Study links social isolation with shrinking brain Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one. Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
Young and middle-aged adults with depression face greater dementia risk later in life Penn In the News USA Today Young and middle-aged adults with depression face greater dementia risk later in life A study led by Holly C. Elser of the Perelman School of Medicine suggests a connection between dementia risk and depression diagnoses in early and mid-life. Is Parkinson’s disease an industrial disorder of our making? Penn In the News Psychology Today Is Parkinson’s disease an industrial disorder of our making? In an op-ed, Anjan Chatterjee of the Perelman School of Medicine examines Parkinson’s disease and its connection to industrialization. AI-guided brain stimulation aids memory in traumatic brain injury Image: iStock/Ozgu Arslan AI-guided brain stimulation aids memory in traumatic brain injury A collaborative study shows that targeted electrical stimulation in the brains of epilepsy patients with traumatic brain injury improved memory recall by 19%. Prescribed stimulants for ADHD and the risk of addiction Penn In the News Psychology Today Prescribed stimulants for ADHD and the risk of addiction Russell Ramsay of the Perelman School of Medicine writes about stimulants as a treatment for ADHD. Study links social isolation with shrinking brain Penn In the News Health Day Study links social isolation with shrinking brain Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one. Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
Is Parkinson’s disease an industrial disorder of our making? Penn In the News Psychology Today Is Parkinson’s disease an industrial disorder of our making? In an op-ed, Anjan Chatterjee of the Perelman School of Medicine examines Parkinson’s disease and its connection to industrialization. AI-guided brain stimulation aids memory in traumatic brain injury Image: iStock/Ozgu Arslan AI-guided brain stimulation aids memory in traumatic brain injury A collaborative study shows that targeted electrical stimulation in the brains of epilepsy patients with traumatic brain injury improved memory recall by 19%. Prescribed stimulants for ADHD and the risk of addiction Penn In the News Psychology Today Prescribed stimulants for ADHD and the risk of addiction Russell Ramsay of the Perelman School of Medicine writes about stimulants as a treatment for ADHD. Study links social isolation with shrinking brain Penn In the News Health Day Study links social isolation with shrinking brain Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one. Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
AI-guided brain stimulation aids memory in traumatic brain injury Image: iStock/Ozgu Arslan AI-guided brain stimulation aids memory in traumatic brain injury A collaborative study shows that targeted electrical stimulation in the brains of epilepsy patients with traumatic brain injury improved memory recall by 19%.
Prescribed stimulants for ADHD and the risk of addiction Penn In the News Psychology Today Prescribed stimulants for ADHD and the risk of addiction Russell Ramsay of the Perelman School of Medicine writes about stimulants as a treatment for ADHD. Study links social isolation with shrinking brain Penn In the News Health Day Study links social isolation with shrinking brain Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one. Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
Study links social isolation with shrinking brain Penn In the News Health Day Study links social isolation with shrinking brain Danielle Sandsmark of the Perelman School of Medicine says that many factors influence dementia risk, and social isolation would be just one. Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
Increasing health equity in Alzheimer’s disease research Penn In the News The Business Journals Increasing health equity in Alzheimer’s disease research The University of Pennsylvania is included in a national outreach and recruitment effort for a $46 million grant from the National Institutes of Health to assist in the inclusion and health equity of treating Alzheimer’s disease in Black patients. New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication. Load More
New federal decisions make Alzheimer’s drug Leqembi widely accessible Penn In the News The New York Times New federal decisions make Alzheimer’s drug Leqembi widely accessible Jason Karlawish of the Perelman School of Medicine is quoted on the risks and benefits of a new Alzheimer’s medication.